title: Better medicines for children--where are we now, and where do we want to be?
authors.affiliation: Novartis Pharma, Basel, Switzerland. klaus.rose@novartis.com
authors.forename: Klaus
authors.initials: K
authors.lastname: Rose
mesh_terms: D002648:Child; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry; D005060:Europe; D006801:Humans; D010372:Pediatrics / Q000331:legislation & jurisprudence* / Q000639:trends; D004364:Pharmaceutical Preparations / Q000592:standards*; D014481:United States
chemical_list: D004364:Pharmaceutical Preparations